[1] |
Aldrich C C. Central nervous system-related pathogens[J]. Acs Infectious Diseases, 2019, 5(12): 1975.
|
[2] |
Daneman R, Prat A. The blood-brain barrier[J]. Cold Spring Harb Perspect Biol, 2015, 7(1): a020412.
|
[3] |
Li Y, Zhong W, Jiang Z, et al. New progress in the approaches for blood-brain barrier protection in acute ischemic stroke[J]. Brain Res Bull, 2019, 144: 46-57.
|
[4] |
Pinheiro M A L, Kooij G, Mizee M R, et al. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke[J]. Biochim Biophys Acta (BBA)-Molecular Basis of Disease, 2016, 1862(3): 461-471.
|
[5] |
钟高亮, 张晶晶. 多物种血脑屏障结构与功能研究进展[J]. 中国实验动物学报, 2020, 28(5): 702-707.
|
[6] |
Pollak T A, Drndarski S, Stone J M, et al. The blood-brain barrier in psychosis[J]. Lancet Psychiatry, 2018, 5(1): 79-92.
|
[7] |
Abdullahi W, Tripathi D, Ronaldson P T. Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection[J]. Am J Physiol Cell Physiol, 2018, 315(3): C343-C356.
|
[8] |
Villain N, Dubois B. Alzheimer's disease including focal presentations[J]. Semin Neurol, 2019, 39(2): 213-226.
|
[9] |
Zenaro E, Piacentino G, Constantin G. The blood-brain barrier in Alzheimer's disease[J]. Neurobiol Dis, 2017, 107: 41-56.
|
[10] |
Cai Z, Qiao P F, Wan C Q, et al. Role of blood-brain barrier in Alzheimer's disease[J]. J Alzheimers Dis, 2018, 63(4): 1223-1234.
|
[11] |
Yamazaki Y, Kanekiyo T. Blood-brain barrier dysfunction and the pathogenesis of Alzheimer's disease[J]. Int J Mol Sci, 2017, 18(9): 1965.
|
[12] |
李文倩, 吕鹤群, 彭拥军, 等. 缺血性脑卒中后血脑屏障损伤机制研究现状[J]. 中国临床药理学杂志, 2020, 36(21): 3533-3537.
|
[13] |
Jiang X, Andjelkovic A V, Zhu L, et al. Blood-brain barrier dysfunction and recovery after ischemic stroke[J]. Prog Neurobiol, 2018, 163/164: 144-171.
|
[14] |
Yang C J, Hawkins K E, Doré S, et al. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke[J]. Am J Physiol Cell Physiol, 2019, 316(2): C135-C153.
|
[15] |
Dadas A, Janigro D. Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy[J]. Neurobiol Dis, 2019, 123: 20-26.
|
[16] |
Rempe R G, Hartz A M S, Soldner E L B, et al. Matrix metalloproteinase-mediated blood-brain barrier dysfunction in epilepsy[J]. J Neurosci, 2018, 38(18): 4301-4315.
|
[17] |
Han H, Mann A, Ekstein D, et al. Breaking bad: the structure and function of the blood-brain barrier in epilepsy[J]. AAPS J, 2017, 19(4): 973-988.
|
[18] |
Swissa E, Serlin Y, Vazana U, et al. Blood-brain barrier dysfunction in status epileptics: mechanisms and role in epileptogenesis[J]. Epilepsy Behav, 2019, 101: 106285.
|
[19] |
何永跃, 陈礼刚. 胶质瘤免疫治疗与血脑屏障[J]. 国际神经病学神经外科学杂志, 2017, 44(1): 68-70.
|
[20] |
Fan K L, Jia X H, Zhou M, et al. Ferritin nanocarrier traverses the blood brain barrier and kills glioma[J]. ACS Nano, 2018, 12(5): 4105-4115.
|
[21] |
Van Tellingen O, Yetkin-Arik B, De Gooijer M C, et al. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment[J]. Drug Resist Updat, 2015, 19: 1-12.
|
[22] |
Lennon V A, Wingerchuk D M, Kryzer T J, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis[J]. Lancet, 2004, 364(9451): 2106-2112.
|
[23] |
张静茹, 董慧芳, 张美妮. 视神经脊髓炎与血脑屏障[J]. 中华脑科疾病与康复杂志(电子版), 2016, 6(3): 177-180.
|
[24] |
Liu H, Qiu K, He Q, et al. Mechanisms of blood-brain barrier disruption in herpes simplex encephalitis[J]. J Neuroimmune Pharmacol, 2019, 14(2): 157-172.
|
[25] |
Niu J Q, Tsai H H, Hoi K K, et al. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation[J]. Nat Neurosci, 2019, 22(5): 709-718.
|